{{Rsnum
|rsid=2300929
|Gene=C5
|Chromosome=9
|position=120954562
|Orientation=plus
|GMAF=0.2089
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=C5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 18.5 | 81.5
| HCB | 6.7 | 22.2 | 71.1
| JPT | 2.3 | 20.5 | 77.3
| YRI | 15.9 | 60.3 | 23.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 22.2 | 71.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|desc=LIVER FIBROSIS, SUSCEPTIBILITY TO
|id=120900
|rsnum=2300929
|variant=0005
}}

{{PMID Auto
|PMID=17428459
|Title=Gc-globulin concentrations and C5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor C5.
}}

{{PMID Auto
|PMID=18644651
|Title=Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}